QL
OTLK icon

Quarry LP’s Outlook Therapeutics OTLK Stock Holding History

Quarry LP’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280 Buy
+176
New +$109 ﹤0.01% 2252

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Quarry LP's OTLK Position: Q2 2026 in Review

Quarry LP opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 176 shares worth $280. The stake represents ﹤0.01% of the portfolio and ranks #2252 among its holdings.

69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Quarry LP held 176 shares of Outlook Therapeutics worth $280 as of Q2 2026.
  • Outlook Therapeutics was a new Quarry LP position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2252 holding.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.